⌘K

Login Start Free

Home/Filings/4/0001213900-19-002982

4//SEC Filing

SETH SANDESH 4

Accession 0001213900-19-002982

CIK 0001388320other

View on SEC.gov Company Profile

Filed

Feb 20, 7:00 PM ET

Accepted

Feb 21, 4:45 PM ET

Size

4.5 KB

Accession

0001213900-19-002982

Insider Transaction Report

Form 4

Period: 2019-02-21

Actinium Pharmaceuticals, Inc.ATNM

Director

Transactions

Exercise of In-Money
Common Stock
2019-02-21$0.60/sh+8,125$4,875→ 161,458 total

Documents

1 file

4
ownership.xmlPrimary

Issuer

Actinium Pharmaceuticals, Inc.

CIK 0001388320

Entity typeother

Related Parties

1

filerCIK 0001566175

Filing Metadata

Form type: 4
Filed: Feb 20, 7:00 PM ET
Accepted: Feb 21, 4:45 PM ET
Size: 4.5 KB

View on SEC.gov